Benefits of Attending & Past Statistics

Industry Benefits of Supporting ISPPD-14

  • Promotes cutting-edge scientific research
  • Contributes to the advancement of Pneumonia and Pneumococc​al Diseases on an international level
  • Offers a unique opportunity to exchange ideas with renowned professionals from across the world
  • Provides an ideal networking forum
  • Offers unique exposure to worldwide markets
  • Offers visibility and interaction during the live event plus three months following the event with on-demand content.

Attendance at ISPPD Over the Years

Statistics from ISPPD-13 in Cape Town

Total Delegates

Total Countries

Total Participants In-Person

Total Participants Online

TOP 20 COUNTRIES

1. US

2. UK

3. South Africa

4. Australia

5. India6. Spain

7. Italy

8. Netherlands

9. Switzerland

10. Belgium11. Brazil

12. China

13. Canada

14. France

15. Denmark16. Kenya

17. Bangladesh

18. Japan

19. Pakistan

20. Sweden

DELEGATES BY SPECIALY (%)

  • Infectious Diseases: 26
  • Microbiology: 22
  • Public Health and General Preventive Medicine: 17
  • Infectious Diseases: 11
  • Pediatric Infectious Desieses: 9
  • Pediatrics: 8
  • Molecular Biology: 2
  • Internal Medicine: 2
  • Allergy & Clinical Immunology: 1
  • Clinical Pharmacology: 1

PARTICIPANTS BY WORKPLACE (%)

PARTICIPANTS BY PROFESSIONAL ROLE (%)

PARTICIPANTS BY AGE (%)

Statistics from ISPPD 2022 – Toronto & Online

Total Registrations

Total Countries

Total Participants In-Person

Total Participants Online

TOP 20 COUNTRIES (%)

PARTICIPANTS BY WORLD REGIONS (%)

PARTICIPANTS BY PROFESSIONAL ROLE (%)

PARTICIPANTS BY WORKPLACE (%)

PARTICIPANTS BY PROFESSIONAL INTEREST (%)